Payment overview · 2025
General Payments
$31.25
1 reported records · 1 companies
Healthcare provider profile · identity verified
Brian Chase, M.D.
Allopathic & Osteopathic Physicians|Hospitalist · CANANDAIGUA, NY · NPI 1881847598
Verified facts
What the public records show
CMS Open Payments records show Brian Chase, M.D. received $31.25 in general payments during 2025 across 1 reported records.
ACADIA Pharmaceuticals Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Nuplazid.
ACADIA Pharmaceuticals Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUPLAZID as an associated drug or biological on 20845 records involving 6448 distinct recipient NPIs. Public Medicare Part D data also shows 109 claims for Nuplazid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $31.25 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $31.25 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $31.25 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| NUPLAZID nuplazid |
2025 | Nuplazid | 2024 | 109 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc Exact reporting entity; no affiliate inference |
2025 | NUPLAZID open payments reported associated product |
CMS Open Payments — General Payments 20845 supporting records · 6448 recipient NPIs · example record 1247763852 |
Nuplazid · 2024 Exact normalized brand match · 1 Part D row |
109 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 600 | 70 |
| Levothyroxine Sodium | Levothyroxine Sodium | 450 | 90 |
| Furosemide | Furosemide | 387 | 69 |
| Gabapentin | Gabapentin | 370 | 71 |
| Atorvastatin Calcium | Atorvastatin Calcium | 360 | 80 |
| Pantoprazole Sodium | Pantoprazole Sodium | 344 | 92 |
| Sertraline Hcl | Sertraline Hcl | 314 | 47 |
| Amlodipine Besylate | Amlodipine Besylate | 273 | 61 |
| Metoprolol Tartrate | Metoprolol Tartrate | 258 | 51 |
| Torsemide | Torsemide | 255 | 51 |
| Xarelto | Rivaroxaban | 242 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 239 | 51 |
| Metoprolol Succinate | Metoprolol Succinate | 208 | 41 |
| Clopidogrel | Clopidogrel Bisulfate | 207 | 38 |
| Trazodone Hcl | Trazodone Hcl | 189 | 34 |
| Losartan Potassium | Losartan Potassium | 184 | 34 |
| Quetiapine Fumarate | Quetiapine Fumarate | 179 | 35 |
| Simvastatin | Simvastatin | 179 | 28 |
| Potassium Chloride | Potassium Chloride | 172 | 42 |
| Levetiracetam | Levetiracetam | 168 | 28 |
| Mirtazapine | Mirtazapine | 166 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 164 | 39 |
| Baclofen | Baclofen | 157 | 22 |
| Metformin Hcl | Metformin Hcl | 157 | 26 |
| Rexulti | Brexpiprazole | 147 | 15 |
| Omeprazole | Omeprazole | 146 | 30 |
| Austedo | Deutetrabenazine | 145 | suppressed |
| Clonazepam | Clonazepam | 144 | 29 |
| Hydralazine Hcl | Hydralazine Hcl | 141 | 32 |
| Divalproex Sodium | Divalproex Sodium | 135 | 21 |
| Warfarin Sodium | Warfarin Sodium | 133 | suppressed |
| Myrbetriq | Mirabegron | 132 | 15 |
| Donepezil Hcl | Donepezil Hcl | 121 | 20 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 118 | 39 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 114 | 21 |
| Famotidine | Famotidine | 111 | 23 |
| Latanoprost | Latanoprost | 111 | 19 |
| Allopurinol | Allopurinol | 110 | 20 |
| Nuplazid | Pimavanserin Tartrate | 109 | suppressed |
| Memantine Hcl | Memantine Hcl | 108 | 19 |
| Klor-Con M10 | Potassium Chloride | 107 | 24 |
| Lisinopril | Lisinopril | 101 | 28 |
| Jardiance | Empagliflozin | 97 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 95 | 15 |
| Sucralfate | Sucralfate | 89 | suppressed |
| Nystatin | Nystatin | 86 | 61 |
| Olanzapine | Olanzapine | 85 | 11 |
| Prednisone | Prednisone | 82 | 34 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 81 | 22 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 80 | 33 |
| Pravastatin Sodium | Pravastatin Sodium | 80 | 17 |
| Carvedilol | Carvedilol | 78 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 76 | 14 |
| Risperidone | Risperidone | 76 | 14 |
| Entresto | Sacubitril/Valsartan | 73 | suppressed |
| Cephalexin | Cephalexin | 72 | 49 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 71 | 38 |
| Lactulose | Lactulose | 71 | 28 |
| Aripiprazole | Aripiprazole | 70 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 63 | 36 |
| Januvia | Sitagliptin Phosphate | 61 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 61 | 19 |
| Lorazepam | Lorazepam | 59 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 55 | 15 |
| Celecoxib | Celecoxib | 54 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 52 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 52 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 52 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 51 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 49 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 49 | 12 |
| Clonidine Hcl | Clonidine Hcl | 48 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 48 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 46 | 45 |
| Fluticasone Propionate | Fluticasone Propionate | 46 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 43 | 24 |
| Haloperidol | Haloperidol | 43 | 15 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 43 | 22 |
| Finasteride | Finasteride | 42 | 14 |
| Methenamine Hippurate | Methenamine Hippurate | 42 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 42 | 25 |
| Dulera | Mometasone/Formoterol | 41 | 18 |
| Ertapenem | Ertapenem Sodium | 40 | 26 |
| Constulose | Lactulose | 39 | 12 |
| Digoxin | Digoxin | 39 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 39 | suppressed |
| Ranolazine Er | Ranolazine | 39 | suppressed |
| Spironolactone | Spironolactone | 39 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 38 | 32 |
| Ramipril | Ramipril | 38 | suppressed |
| Topiramate | Topiramate | 36 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 36 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Levofloxacin | Levofloxacin | 35 | 29 |
| Budesonide | Budesonide | 34 | suppressed |
| Glipizide | Glipizide | 34 | suppressed |
| Alprazolam | Alprazolam | 33 | suppressed |
| Bupropion Xl | Bupropion Hcl | 33 | suppressed |
| Calcitriol | Calcitriol | 32 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 32 | suppressed |
| Lamotrigine | Lamotrigine | 32 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 31 | suppressed |
| Linzess | Linaclotide | 30 | suppressed |
| Fentanyl | Fentanyl | 29 | 11 |
| Valsartan | Valsartan | 29 | suppressed |
| Amantadine | Amantadine Hcl | 28 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 28 | 13 |
| Tiotropium Bromide | Tiotropium Bromide | 28 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 27 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 26 | suppressed |
| Tetrabenazine | Tetrabenazine | 26 | suppressed |
| Timolol Maleate | Timolol Maleate | 26 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 25 | suppressed |
| Hydrocortisone | Hydrocortisone | 24 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 24 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 23 | 18 |
| Labetalol Hcl | Labetalol Hcl | 23 | suppressed |
| Mirabegron Er | Mirabegron | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | suppressed |
| Lubiprostone | Lubiprostone | 22 | suppressed |
| Permethrin | Permethrin | 22 | 22 |
| Tradjenta | Linagliptin | 22 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Phenytoin | Phenytoin | 21 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 21 | 16 |
| Solifenacin Succinate | Solifenacin Succinate | 21 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 20 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Rytary | Carbidopa/Levodopa | 20 | suppressed |
| Scopolamine | Scopolamine | 20 | suppressed |
| Xifaxan | Rifaximin | 20 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 19 | suppressed |
| Metronidazole | Metronidazole | 19 | 11 |
| Novolog Flexpen | Insulin Aspart | 19 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Glimepiride | Glimepiride | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 16 |
| Metformin Hcl Er | Metformin Hcl | 17 | suppressed |
| Phenobarbital | Phenobarbital | 17 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 16 | suppressed |
| Cilostazol | Cilostazol | 16 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 16 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 16 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 16 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Telmisartan | Telmisartan | 15 | suppressed |
| Xcopri | Cenobamate | 15 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 14 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | suppressed |
| Meloxicam | Meloxicam | 14 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 14 | suppressed |
| Sotalol Af | Sotalol Hcl | 14 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 14 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Letrozole | Letrozole | 13 | suppressed |
| Levemir Flexpen | Insulin Detemir | 13 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 13 | 12 |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 12 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Paliperidone Er | Paliperidone | 12 | suppressed |
| Paricalcitol | Paricalcitol | 12 | suppressed |
| Verapamil Sr | Verapamil Hcl | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Clozapine | Clozapine | 11 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 11 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Simbrinza | Brinzolamide/Brimonidine Tart | 11 | suppressed |
| Travoprost | Travoprost | 11 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $31.25 · 1 records | ACADIA Pharmaceuticals Inc | NUPLAZID | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Nuplazid play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ACADIA Pharmaceuticals Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error